HCA250516P370000
- 8.80
- -9.70-52.43%
HCA Healthcare Newsroom
A Quick Look at Today's Ratings for HCA Healthcare(HCA.US), With a Forecast Between $355 to $390
HCA Healthcare Price Target Cut to $376.00/Share From $384.00 by RBC Capital
HCA Healthcare Is Maintained at Outperform by RBC Capital
HCA Healthcare Analyst Ratings
Analysts Conflicted on These Healthcare Names: HCA Healthcare (HCA), Edwards Lifesciences (EW) and Gilead Sciences (GILD)
KeyBanc Maintains HCA Healthcare(HCA.US) With Buy Rating, Maintains Target Price $370
Barclays Maintains HCA Healthcare(HCA.US) With Buy Rating, Maintains Target Price $366
RBC Lowers Price Target on HCA Healthcare to $376 From $384, Keeps Outperform Rating
KeyBanc Keeps Their Buy Rating on HCA Healthcare (HCA)
Barclays Remains a Buy on HCA Healthcare (HCA)
Research Alert: Admissions Growth Remains Healthy As Hca Healthcare Beats Estimates
Wolfe Research Adjusts HCA Healthcare Price Target to $355 From $348
HCA Healthcare Analyst Ratings
Baird Downgrades HCA Healthcare(HCA.US) to Hold Rating, Cuts Target Price to $336
Barclays Maintains HCA Healthcare(HCA.US) With Buy Rating, Maintains Target Price $366
Barclays Sticks to Their Buy Rating for HCA Healthcare (HCA)
HCA Healthcare Analyst Ratings
BofA Securities Maintains HCA Healthcare(HCA.US) With Buy Rating
HCA Healthcare (HCA) Receives a Buy From Bank of America Securities
Cantor Fitzgerald Maintains HCA Healthcare(HCA.US) With Buy Rating, Maintains Target Price $405